Septerna, Inc.
General ticker "SEPN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $927.9M (TTM average)
Septerna, Inc. follows the US Stock Market performance with the rate: 49.9%.
Estimated limits based on current volatility of 4.0%: low 43.28$, high 46.87$
Factors to consider:
- Total employees count: 130 (-99.8%) as of 2025
- Top business risk factors: Limited operating history, Regulatory and compliance, Sales capability establishment, Supply chain disruptions, Expansion into new markets
- Current price 15.6% above estimated high
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [18.14$, 38.00$]
- 2026-12-31 to 2027-12-31 estimated range: [12.95$, 28.49$]
Short-term SEPN quotes
Long-term SEPN plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $4.00MM | $1.07MM | $45.95MM |
| Operating Expenses | $1.92MM | $81.90MM | $114.25MM |
| Operating Income | $2.08MM | $-80.82MM | $-68.30MM |
| Non-Operating Income | $2.80MM | $8.53MM | $19.43MM |
| R&D Expense | $35.98MM | $65.34MM | $97.58MM |
| Income(Loss) | $4.87MM | $-72.30MM | $-48.87MM |
| Taxes | $0.69MM | $-0.50MM | $0.01MM |
| Net Income(Loss)* | $4.18MM | $-71.80MM | $-48.88MM |
| Stockholders Equity | $-38.37MM | $420.05MM | $381.93MM |
| Assets | $130.87MM | $456.55MM | $596.19MM |
| Operating Cash Flow | $-38.72MM | $-67.47MM | $110.19MM |
| Capital expenditure | $2.88MM | $2.10MM | $0.52MM |
| Investing Cash Flow | $22.12MM | $-160.60MM | $-229.35MM |
| Financing Cash Flow | $74.52MM | $377.78MM | $1.69MM |
| Earnings Per Share** | $0.21 | $-1.93 | $-1.10 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.